News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
69,414 Results
Type
Article (1917)
Company Profile (2)
Press Release (67495)
Section
Business (21457)
Career Advice (9)
Deals (4553)
Drug Development (8156)
FDA (1803)
Job Trends (800)
News (37012)
Policy (3560)
Tag
Academia (91)
Alliances (8123)
Alzheimer's disease (121)
Antibody-drug conjugate (ADC) (10)
Approvals (1823)
Artificial intelligence (12)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (15)
Breast cancer (15)
Cancer (168)
Career advice (9)
Cell therapy (18)
Clinical research (6950)
Collaboration (68)
COVID-19 (182)
C-suite (9)
Data (145)
Diabetes (11)
Diagnostics (594)
Drug discovery (12)
Duchenne muscular dystrophy (7)
Earnings (7518)
Events (6910)
Executive appointments (40)
FDA (1907)
Funding (45)
Gene therapy (14)
GLP-1 (40)
Government (233)
Healthcare (1073)
Infectious disease (187)
Inflammatory bowel disease (15)
Intellectual property (8)
IPO (1618)
Job creations (240)
Job search strategy (9)
Layoffs (6)
Legal (948)
Liver cancer (15)
Lung cancer (27)
Lymphoma (10)
Manufacturing (25)
Medical device (1112)
Medtech (1113)
Mergers & acquisitions (3006)
Metabolic disorders (33)
Neuroscience (155)
NextGen: Class of 2025 (219)
Non-profit (61)
Northern California (115)
Obesity (15)
Ovarian cancer (7)
Pancreatic cancer (6)
Parkinson's disease (12)
Patents (13)
People (4935)
Phase I (1886)
Phase II (2904)
Phase III (2640)
Pipeline (66)
Postmarket research (241)
Preclinical (653)
Radiopharmaceuticals (22)
Rare diseases (22)
Real estate (598)
Regulatory (2560)
Research institute (91)
Schizophrenia (6)
Series A (11)
Southern California (112)
Startups (421)
United States (1016)
Vaccines (20)
Date
Last 7 days (39)
Last 30 days (176)
Last 365 days (3149)
2025 (331)
2024 (3253)
2023 (3814)
2022 (7012)
2021 (6372)
2020 (5872)
2019 (3863)
2018 (3010)
2017 (3560)
2016 (3172)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (79)
Arizona (7)
Asia (21251)
Australia (2425)
California (264)
Canada (195)
China (124)
Connecticut (12)
Europe (12343)
Florida (15)
Illinois (16)
India (8)
Japan (58)
Maryland (66)
Massachusetts (185)
Minnesota (25)
New Jersey (146)
New York (118)
North Carolina (53)
Northern California (115)
Pennsylvania (38)
South America (105)
Southern California (112)
Texas (18)
Utah (10)
Virginia (15)
69,414 Results for "phagenesis ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing
September 5, 2024
·
4 min read
Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management
Phagenesis, a pioneering UK company which has developed a revolutionary neurostimulation system to treat swallowing dysfunction, has closed a $42M Series D financing all equity investment round.
March 4, 2024
·
4 min read
Press Releases
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
February 21, 2025
·
4 min read
Phagenesis Launches Phagenyx Neurostimulation System in the U.S.
Phagenesis Ltd, announced that the U.S. Food and Drug Administration has granted a De Novo request for the Phagenyx® Neurostimulation System, a first-of-its-kind therapy that uses pharyngeal electrical stimulation to restore swallowing control in patients with severe dysphagia post stroke.
October 10, 2022
·
3 min read
Press Releases
BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB
January 8, 2025
·
1 min read
Press Releases
WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024
November 28, 2024
·
4 min read
Press Releases
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
February 11, 2025
·
6 min read
Press Releases
AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.
December 24, 2024
·
8 min read
Press Releases
AI/ML Innovations to Acquire Quantum Sciences Ltd
December 10, 2024
·
4 min read
Press Releases
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
January 24, 2025
·
5 min read
1 of 6,942
Next
